Mettler-Toledo International Inc. (NYSE: MTD) Stock Competitors & Peer Comparison
See MTD's competitors and their performance on the NYSE and across the wider stock market.
Peer Comparison Table: Medical - Diagnostics & Research Industry
Detailed financial metrics including price, market cap, P/E ratio, and more for MTD and its NYSE peers.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| MTD | $1,669.62 | -0.04% | 33.5B | 38.40 | $43.51 | N/A |
| DHR-PB | $1,261.26 | -0.78% | 916.8B | 146.01 | $8.64 | +0.66% |
| TMO | $684.89 | +1.64% | 253.2B | 29.56 | $23.16 | +0.27% |
| DHR | $232.97 | +1.07% | 163.8B | 29.19 | $7.98 | +0.66% |
| NTRA | $404.90 | +0.24% | 58.4B | -306.74 | -$1.32 | N/A |
| A | $175.96 | +1.67% | 49.6B | 30.28 | $5.81 | +0.58% |
| IQV | $273.60 | -2.06% | 45B | 22.55 | $12.13 | N/A |
| IDXX | $570.21 | +1.75% | 44.9B | 40.10 | $14.22 | N/A |
| WAT | $455.98 | +0.51% | 44.8B | 33.33 | $13.68 | N/A |
| ILMN | $271.04 | +0.60% | 40.9B | 53.88 | $5.03 | N/A |
Stock Comparison
Danaher Corporation (NYSE: DHR-PB)
MTD vs DHR-PB Comparison October 2026
Mettler-Toledo International Inc. (NYSE: MTD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MTD stands at 33.5B. In comparison, DHR-PB has a market cap of 916.8B. Regarding current trading prices, MTD is priced at $1,669.62 on the NYSE, while DHR-PB trades at $1,261.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MTD currently has a P/E ratio of 38.40, whereas DHR-PB's P/E ratio is 146.01. In terms of profitability, MTD's ROE is -12.00%, compared to DHR-PB's ROE of +0.08%. Regarding short-term risk, MTD is more volatile compared to DHR-PB. This indicates higher risk in terms of short-term price fluctuations for MTD.Check DHR-PB's competition here
Thermo Fisher Scientific Inc. (NYSE: TMO)
MTD vs TMO Comparison October 2026
Mettler-Toledo International Inc. (NYSE: MTD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MTD stands at 33.5B. In comparison, TMO has a market cap of 253.2B. Regarding current trading prices, MTD is priced at $1,669.62 on the NYSE, while TMO trades at $684.89.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MTD currently has a P/E ratio of 38.40, whereas TMO's P/E ratio is 29.56. In terms of profitability, MTD's ROE is -12.00%, compared to TMO's ROE of +0.13%. Regarding short-term risk, MTD is less volatile compared to TMO. This indicates lower risk in terms of short-term price fluctuations for MTD.Check TMO's competition here
Danaher Corporation (NYSE: DHR)
MTD vs DHR Comparison October 2026
Mettler-Toledo International Inc. (NYSE: MTD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MTD stands at 33.5B. In comparison, DHR has a market cap of 163.8B. Regarding current trading prices, MTD is priced at $1,669.62 on the NYSE, while DHR trades at $232.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MTD currently has a P/E ratio of 38.40, whereas DHR's P/E ratio is 29.19. In terms of profitability, MTD's ROE is -12.00%, compared to DHR's ROE of +0.08%. Regarding short-term risk, MTD is less volatile compared to DHR. This indicates lower risk in terms of short-term price fluctuations for MTD.Check DHR's competition here
Natera, Inc. (NASDAQ: NTRA)
MTD vs NTRA Comparison October 2026
Mettler-Toledo International Inc. (NYSE: MTD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MTD stands at 33.5B. In comparison, NTRA has a market cap of 58.4B. Regarding current trading prices, MTD is priced at $1,669.62 on the NYSE, while NTRA trades at $404.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MTD currently has a P/E ratio of 38.40, whereas NTRA's P/E ratio is -306.74. In terms of profitability, MTD's ROE is -12.00%, compared to NTRA's ROE of -0.12%. Regarding short-term risk, MTD is less volatile compared to NTRA. This indicates lower risk in terms of short-term price fluctuations for MTD.Check NTRA's competition here
Agilent Technologies, Inc. (NYSE: A)
MTD vs A Comparison October 2026
Mettler-Toledo International Inc. (NYSE: MTD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MTD stands at 33.5B. In comparison, A has a market cap of 49.6B. Regarding current trading prices, MTD is priced at $1,669.62 on the NYSE, while A trades at $175.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MTD currently has a P/E ratio of 38.40, whereas A's P/E ratio is 30.28. In terms of profitability, MTD's ROE is -12.00%, compared to A's ROE of +0.20%. Regarding short-term risk, MTD is less volatile compared to A. This indicates lower risk in terms of short-term price fluctuations for MTD.Check A's competition here
IQVIA Holdings Inc. (NYSE: IQV)
MTD vs IQV Comparison October 2026
Mettler-Toledo International Inc. (NYSE: MTD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MTD stands at 33.5B. In comparison, IQV has a market cap of 45B. Regarding current trading prices, MTD is priced at $1,669.62 on the NYSE, while IQV trades at $273.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MTD currently has a P/E ratio of 38.40, whereas IQV's P/E ratio is 22.55. In terms of profitability, MTD's ROE is -12.00%, compared to IQV's ROE of +0.22%. Regarding short-term risk, MTD is less volatile compared to IQV. This indicates lower risk in terms of short-term price fluctuations for MTD.Check IQV's competition here
IDEXX Laboratories, Inc. (NASDAQ: IDXX)
MTD vs IDXX Comparison October 2026
Mettler-Toledo International Inc. (NYSE: MTD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MTD stands at 33.5B. In comparison, IDXX has a market cap of 44.9B. Regarding current trading prices, MTD is priced at $1,669.62 on the NYSE, while IDXX trades at $570.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MTD currently has a P/E ratio of 38.40, whereas IDXX's P/E ratio is 40.10. In terms of profitability, MTD's ROE is -12.00%, compared to IDXX's ROE of +0.72%. Regarding short-term risk, MTD is less volatile compared to IDXX. This indicates lower risk in terms of short-term price fluctuations for MTD.Check IDXX's competition here
Waters Corporation (NYSE: WAT)
MTD vs WAT Comparison October 2026
Mettler-Toledo International Inc. (NYSE: MTD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MTD stands at 33.5B. In comparison, WAT has a market cap of 44.8B. Regarding current trading prices, MTD is priced at $1,669.62 on the NYSE, while WAT trades at $455.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MTD currently has a P/E ratio of 38.40, whereas WAT's P/E ratio is 33.33. In terms of profitability, MTD's ROE is -12.00%, compared to WAT's ROE of +0.02%. Regarding short-term risk, MTD is less volatile compared to WAT. This indicates lower risk in terms of short-term price fluctuations for MTD.Check WAT's competition here
Illumina, Inc. (NASDAQ: ILMN)
MTD vs ILMN Comparison October 2026
Mettler-Toledo International Inc. (NYSE: MTD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MTD stands at 33.5B. In comparison, ILMN has a market cap of 40.9B. Regarding current trading prices, MTD is priced at $1,669.62 on the NYSE, while ILMN trades at $271.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MTD currently has a P/E ratio of 38.40, whereas ILMN's P/E ratio is 53.88. In terms of profitability, MTD's ROE is -12.00%, compared to ILMN's ROE of +0.31%. Regarding short-term risk, MTD is less volatile compared to ILMN. This indicates lower risk in terms of short-term price fluctuations for MTD.Check ILMN's competition here
Quest Diagnostics Incorporated (NYSE: DGX)
MTD vs DGX Comparison October 2026
Mettler-Toledo International Inc. (NYSE: MTD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MTD stands at 33.5B. In comparison, DGX has a market cap of 26.8B. Regarding current trading prices, MTD is priced at $1,669.62 on the NYSE, while DGX trades at $242.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MTD currently has a P/E ratio of 38.40, whereas DGX's P/E ratio is 23.96. In terms of profitability, MTD's ROE is -12.00%, compared to DGX's ROE of +0.15%. Regarding short-term risk, MTD is less volatile compared to DGX. This indicates lower risk in terms of short-term price fluctuations for MTD.Check DGX's competition here
Labcorp Holdings Inc. (NYSE: LH)
MTD vs LH Comparison October 2026
Mettler-Toledo International Inc. (NYSE: MTD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MTD stands at 33.5B. In comparison, LH has a market cap of 26.8B. Regarding current trading prices, MTD is priced at $1,669.62 on the NYSE, while LH trades at $329.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MTD currently has a P/E ratio of 38.40, whereas LH's P/E ratio is 19.58. In terms of profitability, MTD's ROE is -12.00%, compared to LH's ROE of +0.12%. Regarding short-term risk, MTD is less volatile compared to LH. This indicates lower risk in terms of short-term price fluctuations for MTD.Check LH's competition here
Guardant Health, Inc. (NASDAQ: GH)
MTD vs GH Comparison October 2026
Mettler-Toledo International Inc. (NYSE: MTD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MTD stands at 33.5B. In comparison, GH has a market cap of 23.2B. Regarding current trading prices, MTD is priced at $1,669.62 on the NYSE, while GH trades at $173.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MTD currently has a P/E ratio of 38.40, whereas GH's P/E ratio is -49.64. In terms of profitability, MTD's ROE is -12.00%, compared to GH's ROE of +2.11%. Regarding short-term risk, MTD is less volatile compared to GH. This indicates lower risk in terms of short-term price fluctuations for MTD.Check GH's competition here
Exact Sciences Corporation (NASDAQ: EXAS)
MTD vs EXAS Comparison October 2026
Mettler-Toledo International Inc. (NYSE: MTD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MTD stands at 33.5B. In comparison, EXAS has a market cap of 20B. Regarding current trading prices, MTD is priced at $1,669.62 on the NYSE, while EXAS trades at $104.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MTD currently has a P/E ratio of 38.40, whereas EXAS's P/E ratio is -95.37. In terms of profitability, MTD's ROE is -12.00%, compared to EXAS's ROE of -0.04%. Regarding short-term risk, MTD is more volatile compared to EXAS. This indicates higher risk in terms of short-term price fluctuations for MTD.Check EXAS's competition here
Medpace Holdings, Inc. (NASDAQ: MEDP)
MTD vs MEDP Comparison October 2026
Mettler-Toledo International Inc. (NYSE: MTD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MTD stands at 33.5B. In comparison, MEDP has a market cap of 18.9B. Regarding current trading prices, MTD is priced at $1,669.62 on the NYSE, while MEDP trades at $676.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MTD currently has a P/E ratio of 38.40, whereas MEDP's P/E ratio is 39.67. In terms of profitability, MTD's ROE is -12.00%, compared to MEDP's ROE of +1.00%. Regarding short-term risk, MTD is less volatile compared to MEDP. This indicates lower risk in terms of short-term price fluctuations for MTD.Check MEDP's competition here
Revvity, Inc. (NYSE: RVTY)
MTD vs RVTY Comparison October 2026
Mettler-Toledo International Inc. (NYSE: MTD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MTD stands at 33.5B. In comparison, RVTY has a market cap of 17.9B. Regarding current trading prices, MTD is priced at $1,669.62 on the NYSE, while RVTY trades at $160.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MTD currently has a P/E ratio of 38.40, whereas RVTY's P/E ratio is 29.98. In terms of profitability, MTD's ROE is -12.00%, compared to RVTY's ROE of +0.03%. Regarding short-term risk, MTD is less volatile compared to RVTY. This indicates lower risk in terms of short-term price fluctuations for MTD.Check RVTY's competition here
Charles River Laboratories International, Inc. (NYSE: CRL)
MTD vs CRL Comparison October 2026
Mettler-Toledo International Inc. (NYSE: MTD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MTD stands at 33.5B. In comparison, CRL has a market cap of 17.2B. Regarding current trading prices, MTD is priced at $1,669.62 on the NYSE, while CRL trades at $357.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MTD currently has a P/E ratio of 38.40, whereas CRL's P/E ratio is 36.07. In terms of profitability, MTD's ROE is -12.00%, compared to CRL's ROE of -0.08%. Regarding short-term risk, MTD is less volatile compared to CRL. This indicates lower risk in terms of short-term price fluctuations for MTD.Check CRL's competition here
Illumina, Inc. Common Stock Ex-distribution When-Issued (NASDAQ: ILMNV)
MTD vs ILMNV Comparison October 2026
Mettler-Toledo International Inc. (NYSE: MTD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MTD stands at 33.5B. In comparison, ILMNV has a market cap of 17B. Regarding current trading prices, MTD is priced at $1,669.62 on the NYSE, while ILMNV trades at $107.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MTD currently has a P/E ratio of 38.40, whereas ILMNV's P/E ratio is N/A. In terms of profitability, MTD's ROE is -12.00%, compared to ILMNV's ROE of N/A. Regarding short-term risk, MTD is more volatile compared to ILMNV. This indicates higher risk in terms of short-term price fluctuations for MTD.Check ILMNV's competition here
PerkinElmer, Inc. (NYSE: PKI)
MTD vs PKI Comparison October 2026
Mettler-Toledo International Inc. (NYSE: MTD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MTD stands at 33.5B. In comparison, PKI has a market cap of 14.5B. Regarding current trading prices, MTD is priced at $1,669.62 on the NYSE, while PKI trades at $115.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MTD currently has a P/E ratio of 38.40, whereas PKI's P/E ratio is 41.45. In terms of profitability, MTD's ROE is -12.00%, compared to PKI's ROE of +0.03%. Regarding short-term risk, MTD is less volatile compared to PKI. This indicates lower risk in terms of short-term price fluctuations for MTD.Check PKI's competition here
ICON Public Limited Company (NASDAQ: ICLR)
MTD vs ICLR Comparison October 2026
Mettler-Toledo International Inc. (NYSE: MTD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MTD stands at 33.5B. In comparison, ICLR has a market cap of 14.2B. Regarding current trading prices, MTD is priced at $1,669.62 on the NYSE, while ICLR trades at $183.78.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MTD currently has a P/E ratio of 38.40, whereas ICLR's P/E ratio is 14.99. In terms of profitability, MTD's ROE is -12.00%, compared to ICLR's ROE of +0.04%. Regarding short-term risk, MTD is less volatile compared to ICLR. This indicates lower risk in terms of short-term price fluctuations for MTD.Check ICLR's competition here
Qiagen N.V. (NYSE: QGEN)
MTD vs QGEN Comparison October 2026
Mettler-Toledo International Inc. (NYSE: MTD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MTD stands at 33.5B. In comparison, QGEN has a market cap of 10.4B. Regarding current trading prices, MTD is priced at $1,669.62 on the NYSE, while QGEN trades at $50.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MTD currently has a P/E ratio of 38.40, whereas QGEN's P/E ratio is 20.81. In terms of profitability, MTD's ROE is -12.00%, compared to QGEN's ROE of +0.12%. Regarding short-term risk, MTD is more volatile compared to QGEN. This indicates higher risk in terms of short-term price fluctuations for MTD.Check QGEN's competition here
GRAIL Inc. (NASDAQ: GRAL)
MTD vs GRAL Comparison October 2026
Mettler-Toledo International Inc. (NYSE: MTD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MTD stands at 33.5B. In comparison, GRAL has a market cap of 6.2B. Regarding current trading prices, MTD is priced at $1,669.62 on the NYSE, while GRAL trades at $139.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MTD currently has a P/E ratio of 38.40, whereas GRAL's P/E ratio is -14.35. In terms of profitability, MTD's ROE is -12.00%, compared to GRAL's ROE of -0.16%. Regarding short-term risk, MTD is less volatile compared to GRAL. This indicates lower risk in terms of short-term price fluctuations for MTD.Check GRAL's competition here
RadNet, Inc. (NASDAQ: RDNT)
MTD vs RDNT Comparison October 2026
Mettler-Toledo International Inc. (NYSE: MTD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MTD stands at 33.5B. In comparison, RDNT has a market cap of 5.5B. Regarding current trading prices, MTD is priced at $1,669.62 on the NYSE, while RDNT trades at $70.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MTD currently has a P/E ratio of 38.40, whereas RDNT's P/E ratio is 152.28. In terms of profitability, MTD's ROE is -12.00%, compared to RDNT's ROE of -0.02%. Regarding short-term risk, MTD is less volatile compared to RDNT. This indicates lower risk in terms of short-term price fluctuations for MTD.Check RDNT's competition here
BillionToOne, Inc. (NASDAQ: BLLN)
MTD vs BLLN Comparison October 2026
Mettler-Toledo International Inc. (NYSE: MTD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MTD stands at 33.5B. In comparison, BLLN has a market cap of 5.3B. Regarding current trading prices, MTD is priced at $1,669.62 on the NYSE, while BLLN trades at $111.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MTD currently has a P/E ratio of 38.40, whereas BLLN's P/E ratio is 159.24. In terms of profitability, MTD's ROE is -12.00%, compared to BLLN's ROE of +0.08%. Regarding short-term risk, MTD is less volatile compared to BLLN. This indicates lower risk in terms of short-term price fluctuations for MTD.Check BLLN's competition here
Sotera Health Company (NASDAQ: SHC)
MTD vs SHC Comparison October 2026
Mettler-Toledo International Inc. (NYSE: MTD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MTD stands at 33.5B. In comparison, SHC has a market cap of 5.2B. Regarding current trading prices, MTD is priced at $1,669.62 on the NYSE, while SHC trades at $18.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MTD currently has a P/E ratio of 38.40, whereas SHC's P/E ratio is 19.16. In terms of profitability, MTD's ROE is -12.00%, compared to SHC's ROE of +0.27%. Regarding short-term risk, MTD is less volatile compared to SHC. This indicates lower risk in terms of short-term price fluctuations for MTD.Check SHC's competition here
Syneos Health, Inc. (NASDAQ: SYNH)
MTD vs SYNH Comparison October 2026
Mettler-Toledo International Inc. (NYSE: MTD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MTD stands at 33.5B. In comparison, SYNH has a market cap of 4.5B. Regarding current trading prices, MTD is priced at $1,669.62 on the NYSE, while SYNH trades at $42.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MTD currently has a P/E ratio of 38.40, whereas SYNH's P/E ratio is 61.40. In terms of profitability, MTD's ROE is -12.00%, compared to SYNH's ROE of +0.08%. Regarding short-term risk, MTD is more volatile compared to SYNH. This indicates higher risk in terms of short-term price fluctuations for MTD.Check SYNH's competition here
Veracyte, Inc. (NASDAQ: VCYT)
MTD vs VCYT Comparison October 2026
Mettler-Toledo International Inc. (NYSE: MTD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MTD stands at 33.5B. In comparison, VCYT has a market cap of 3.9B. Regarding current trading prices, MTD is priced at $1,669.62 on the NYSE, while VCYT trades at $48.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MTD currently has a P/E ratio of 38.40, whereas VCYT's P/E ratio is 24.10. In terms of profitability, MTD's ROE is -12.00%, compared to VCYT's ROE of +0.09%. Regarding short-term risk, MTD is less volatile compared to VCYT. This indicates lower risk in terms of short-term price fluctuations for MTD.Check VCYT's competition here
CareDx, Inc (NASDAQ: CDNA)
MTD vs CDNA Comparison October 2026
Mettler-Toledo International Inc. (NYSE: MTD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MTD stands at 33.5B. In comparison, CDNA has a market cap of 3.6B. Regarding current trading prices, MTD is priced at $1,669.62 on the NYSE, while CDNA trades at $69.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MTD currently has a P/E ratio of 38.40, whereas CDNA's P/E ratio is 82.26. In terms of profitability, MTD's ROE is -12.00%, compared to CDNA's ROE of +0.33%. Regarding short-term risk, MTD is less volatile compared to CDNA. This indicates lower risk in terms of short-term price fluctuations for MTD.Check CDNA's competition here
Olink Holding AB (publ) (NASDAQ: OLK)
MTD vs OLK Comparison October 2026
Mettler-Toledo International Inc. (NYSE: MTD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MTD stands at 33.5B. In comparison, OLK has a market cap of 3.2B. Regarding current trading prices, MTD is priced at $1,669.62 on the NYSE, while OLK trades at $26.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MTD currently has a P/E ratio of 38.40, whereas OLK's P/E ratio is -96.59. In terms of profitability, MTD's ROE is -12.00%, compared to OLK's ROE of -0.07%. Regarding short-term risk, MTD is more volatile compared to OLK. This indicates higher risk in terms of short-term price fluctuations for MTD.Check OLK's competition here
NeoGenomics, Inc. (NASDAQ: NEO)
MTD vs NEO Comparison October 2026
Mettler-Toledo International Inc. (NYSE: MTD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MTD stands at 33.5B. In comparison, NEO has a market cap of 2.2B. Regarding current trading prices, MTD is priced at $1,669.62 on the NYSE, while NEO trades at $16.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MTD currently has a P/E ratio of 38.40, whereas NEO's P/E ratio is 128.38. In terms of profitability, MTD's ROE is -12.00%, compared to NEO's ROE of -0.06%. Regarding short-term risk, MTD is less volatile compared to NEO. This indicates lower risk in terms of short-term price fluctuations for MTD.Check NEO's competition here
GeneDx Holdings Corp. (NASDAQ: WGS)
MTD vs WGS Comparison October 2026
Mettler-Toledo International Inc. (NYSE: MTD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MTD stands at 33.5B. In comparison, WGS has a market cap of 1.8B. Regarding current trading prices, MTD is priced at $1,669.62 on the NYSE, while WGS trades at $61.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MTD currently has a P/E ratio of 38.40, whereas WGS's P/E ratio is 170.17. In terms of profitability, MTD's ROE is -12.00%, compared to WGS's ROE of -0.39%. Regarding short-term risk, MTD is less volatile compared to WGS. This indicates lower risk in terms of short-term price fluctuations for MTD.Check WGS's competition here
Personalis, Inc. (NASDAQ: PSNL)
MTD vs PSNL Comparison October 2026
Mettler-Toledo International Inc. (NYSE: MTD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MTD stands at 33.5B. In comparison, PSNL has a market cap of 1.7B. Regarding current trading prices, MTD is priced at $1,669.62 on the NYSE, while PSNL trades at $15.88.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MTD currently has a P/E ratio of 38.40, whereas PSNL's P/E ratio is -14.57. In terms of profitability, MTD's ROE is -12.00%, compared to PSNL's ROE of -0.46%. Regarding short-term risk, MTD is less volatile compared to PSNL. This indicates lower risk in terms of short-term price fluctuations for MTD.Check PSNL's competition here
OPKO Health, Inc. (NASDAQ: OPK)
MTD vs OPK Comparison October 2026
Mettler-Toledo International Inc. (NYSE: MTD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MTD stands at 33.5B. In comparison, OPK has a market cap of 1.2B. Regarding current trading prices, MTD is priced at $1,669.62 on the NYSE, while OPK trades at $1.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MTD currently has a P/E ratio of 38.40, whereas OPK's P/E ratio is -18.11. In terms of profitability, MTD's ROE is -12.00%, compared to OPK's ROE of -0.06%. Regarding short-term risk, MTD is less volatile compared to OPK. This indicates lower risk in terms of short-term price fluctuations for MTD.Check OPK's competition here
Castle Biosciences, Inc. (NASDAQ: CSTL)
MTD vs CSTL Comparison October 2026
Mettler-Toledo International Inc. (NYSE: MTD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MTD stands at 33.5B. In comparison, CSTL has a market cap of 1B. Regarding current trading prices, MTD is priced at $1,669.62 on the NYSE, while CSTL trades at $33.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MTD currently has a P/E ratio of 38.40, whereas CSTL's P/E ratio is -50.45. In terms of profitability, MTD's ROE is -12.00%, compared to CSTL's ROE of -0.04%. Regarding short-term risk, MTD is less volatile compared to CSTL. This indicates lower risk in terms of short-term price fluctuations for MTD.Check CSTL's competition here
GRAIL, Inc. Common Stock (NASDAQ: GRALV)
MTD vs GRALV Comparison October 2026
Mettler-Toledo International Inc. (NYSE: MTD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MTD stands at 33.5B. In comparison, GRALV has a market cap of 579.4M. Regarding current trading prices, MTD is priced at $1,669.62 on the NYSE, while GRALV trades at $18.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MTD currently has a P/E ratio of 38.40, whereas GRALV's P/E ratio is N/A. In terms of profitability, MTD's ROE is -12.00%, compared to GRALV's ROE of N/A. Regarding short-term risk, MTD is less volatile compared to GRALV. This indicates lower risk in terms of short-term price fluctuations for MTD.Check GRALV's competition here
Myriad Genetics, Inc. (NASDAQ: MYGN)
MTD vs MYGN Comparison October 2026
Mettler-Toledo International Inc. (NYSE: MTD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MTD stands at 33.5B. In comparison, MYGN has a market cap of 575.8M. Regarding current trading prices, MTD is priced at $1,669.62 on the NYSE, while MYGN trades at $6.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MTD currently has a P/E ratio of 38.40, whereas MYGN's P/E ratio is -46.31. In terms of profitability, MTD's ROE is -12.00%, compared to MYGN's ROE of -0.33%. Regarding short-term risk, MTD is less volatile compared to MYGN. This indicates lower risk in terms of short-term price fluctuations for MTD.Check MYGN's competition here
Fulgent Genetics, Inc. (NASDAQ: FLGT)
MTD vs FLGT Comparison October 2026
Mettler-Toledo International Inc. (NYSE: MTD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MTD stands at 33.5B. In comparison, FLGT has a market cap of 556.4M. Regarding current trading prices, MTD is priced at $1,669.62 on the NYSE, while FLGT trades at $20.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MTD currently has a P/E ratio of 38.40, whereas FLGT's P/E ratio is 2022.00. In terms of profitability, MTD's ROE is -12.00%, compared to FLGT's ROE of -0.08%. Regarding short-term risk, MTD is less volatile compared to FLGT. This indicates lower risk in terms of short-term price fluctuations for MTD.Check FLGT's competition here
Global Cord Blood Corporation (NYSE: CO)
MTD vs CO Comparison October 2026
Mettler-Toledo International Inc. (NYSE: MTD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MTD stands at 33.5B. In comparison, CO has a market cap of 400.1M. Regarding current trading prices, MTD is priced at $1,669.62 on the NYSE, while CO trades at $2.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MTD currently has a P/E ratio of 38.40, whereas CO's P/E ratio is 5.06. In terms of profitability, MTD's ROE is -12.00%, compared to CO's ROE of +0.11%. Regarding short-term risk, MTD is less volatile compared to CO. This indicates lower risk in terms of short-term price fluctuations for MTD.Check CO's competition here
Standard BioTools Inc. (NASDAQ: FLDM)
MTD vs FLDM Comparison October 2026
Mettler-Toledo International Inc. (NYSE: MTD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MTD stands at 33.5B. In comparison, FLDM has a market cap of 294.2M. Regarding current trading prices, MTD is priced at $1,669.62 on the NYSE, while FLDM trades at $3.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MTD currently has a P/E ratio of 38.40, whereas FLDM's P/E ratio is -4.74. In terms of profitability, MTD's ROE is -12.00%, compared to FLDM's ROE of +0.18%. Regarding short-term risk, MTD is less volatile compared to FLDM. This indicates lower risk in terms of short-term price fluctuations for MTD.Check FLDM's competition here
Exagen Inc. (NASDAQ: XGN)
MTD vs XGN Comparison October 2026
Mettler-Toledo International Inc. (NYSE: MTD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MTD stands at 33.5B. In comparison, XGN has a market cap of 181M. Regarding current trading prices, MTD is priced at $1,669.62 on the NYSE, while XGN trades at $7.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MTD currently has a P/E ratio of 38.40, whereas XGN's P/E ratio is -9.22. In terms of profitability, MTD's ROE is -12.00%, compared to XGN's ROE of -1.22%. Regarding short-term risk, MTD is less volatile compared to XGN. This indicates lower risk in terms of short-term price fluctuations for MTD.Check XGN's competition here
Biodesix, Inc. (NASDAQ: BDSX)
MTD vs BDSX Comparison October 2026
Mettler-Toledo International Inc. (NYSE: MTD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MTD stands at 33.5B. In comparison, BDSX has a market cap of 173.1M. Regarding current trading prices, MTD is priced at $1,669.62 on the NYSE, while BDSX trades at $21.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MTD currently has a P/E ratio of 38.40, whereas BDSX's P/E ratio is -6.71. In terms of profitability, MTD's ROE is -12.00%, compared to BDSX's ROE of -7.88%. Regarding short-term risk, MTD is less volatile compared to BDSX. This indicates lower risk in terms of short-term price fluctuations for MTD.Check BDSX's competition here
Genetron Holdings Limited (NASDAQ: GTH)
MTD vs GTH Comparison October 2026
Mettler-Toledo International Inc. (NYSE: MTD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MTD stands at 33.5B. In comparison, GTH has a market cap of 127.3M. Regarding current trading prices, MTD is priced at $1,669.62 on the NYSE, while GTH trades at $4.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MTD currently has a P/E ratio of 38.40, whereas GTH's P/E ratio is -1.11. In terms of profitability, MTD's ROE is -12.00%, compared to GTH's ROE of -1.01%. Regarding short-term risk, MTD is more volatile compared to GTH. This indicates higher risk in terms of short-term price fluctuations for MTD.Check GTH's competition here
Genetic Technologies Limited (NASDAQ: GENE)
MTD vs GENE Comparison October 2026
Mettler-Toledo International Inc. (NYSE: MTD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MTD stands at 33.5B. In comparison, GENE has a market cap of 111.2M. Regarding current trading prices, MTD is priced at $1,669.62 on the NYSE, while GENE trades at $0.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MTD currently has a P/E ratio of 38.40, whereas GENE's P/E ratio is -38.25. In terms of profitability, MTD's ROE is -12.00%, compared to GENE's ROE of -1.85%. Regarding short-term risk, MTD is more volatile compared to GENE. This indicates higher risk in terms of short-term price fluctuations for MTD.Check GENE's competition here
Freenome, Inc. (NASDAQ: FRNM)
MTD vs FRNM Comparison October 2026
Mettler-Toledo International Inc. (NYSE: MTD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MTD stands at 33.5B. In comparison, FRNM has a market cap of 103.8M. Regarding current trading prices, MTD is priced at $1,669.62 on the NYSE, while FRNM trades at $12.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MTD currently has a P/E ratio of 38.40, whereas FRNM's P/E ratio is N/A. In terms of profitability, MTD's ROE is -12.00%, compared to FRNM's ROE of N/A. Regarding short-term risk, MTD is less volatile compared to FRNM. This indicates lower risk in terms of short-term price fluctuations for MTD.Check FRNM's competition here
Insight Molecular Diagnostics Inc. (NASDAQ: IMDX)
MTD vs IMDX Comparison October 2026
Mettler-Toledo International Inc. (NYSE: MTD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MTD stands at 33.5B. In comparison, IMDX has a market cap of 98.2M. Regarding current trading prices, MTD is priced at $1,669.62 on the NYSE, while IMDX trades at $3.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MTD currently has a P/E ratio of 38.40, whereas IMDX's P/E ratio is -2.01. In terms of profitability, MTD's ROE is -12.00%, compared to IMDX's ROE of +2.72%. Regarding short-term risk, MTD is less volatile compared to IMDX. This indicates lower risk in terms of short-term price fluctuations for MTD.Check IMDX's competition here
Precipio, Inc. (NASDAQ: PRPO)
MTD vs PRPO Comparison October 2026
Mettler-Toledo International Inc. (NYSE: MTD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MTD stands at 33.5B. In comparison, PRPO has a market cap of 35M. Regarding current trading prices, MTD is priced at $1,669.62 on the NYSE, while PRPO trades at $19.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MTD currently has a P/E ratio of 38.40, whereas PRPO's P/E ratio is -30.08. In terms of profitability, MTD's ROE is -12.00%, compared to PRPO's ROE of -0.08%. Regarding short-term risk, MTD is less volatile compared to PRPO. This indicates lower risk in terms of short-term price fluctuations for MTD.Check PRPO's competition here
Akumin Inc. (NASDAQ: AKU)
MTD vs AKU Comparison October 2026
Mettler-Toledo International Inc. (NYSE: MTD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MTD stands at 33.5B. In comparison, AKU has a market cap of 26.3M. Regarding current trading prices, MTD is priced at $1,669.62 on the NYSE, while AKU trades at $0.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MTD currently has a P/E ratio of 38.40, whereas AKU's P/E ratio is -0.13. In terms of profitability, MTD's ROE is -12.00%, compared to AKU's ROE of -5.32%. Regarding short-term risk, MTD is less volatile compared to AKU. This indicates lower risk in terms of short-term price fluctuations for MTD.Check AKU's competition here
Quantum Cyber N.V. (NASDAQ: QUCY)
MTD vs QUCY Comparison October 2026
Mettler-Toledo International Inc. (NYSE: MTD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MTD stands at 33.5B. In comparison, QUCY has a market cap of 19.4M. Regarding current trading prices, MTD is priced at $1,669.62 on the NYSE, while QUCY trades at $0.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MTD currently has a P/E ratio of 38.40, whereas QUCY's P/E ratio is -0.04. In terms of profitability, MTD's ROE is -12.00%, compared to QUCY's ROE of -3.65%. Regarding short-term risk, MTD is less volatile compared to QUCY. This indicates lower risk in terms of short-term price fluctuations for MTD.Check QUCY's competition here
MDxHealth S.A. (NASDAQ: MDXH)
MTD vs MDXH Comparison October 2026
Mettler-Toledo International Inc. (NYSE: MTD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MTD stands at 33.5B. In comparison, MDXH has a market cap of 18.6M. Regarding current trading prices, MTD is priced at $1,669.62 on the NYSE, while MDXH trades at $0.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MTD currently has a P/E ratio of 38.40, whereas MDXH's P/E ratio is -0.27. In terms of profitability, MTD's ROE is -12.00%, compared to MDXH's ROE of +1.43%. Regarding short-term risk, MTD is less volatile compared to MDXH. This indicates lower risk in terms of short-term price fluctuations for MTD.Check MDXH's competition here
bioAffinity Technologies, Inc. (NASDAQ: BIAF)
MTD vs BIAF Comparison October 2026
Mettler-Toledo International Inc. (NYSE: MTD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MTD stands at 33.5B. In comparison, BIAF has a market cap of 17.8M. Regarding current trading prices, MTD is priced at $1,669.62 on the NYSE, while BIAF trades at $2.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MTD currently has a P/E ratio of 38.40, whereas BIAF's P/E ratio is -0.33. In terms of profitability, MTD's ROE is -12.00%, compared to BIAF's ROE of -2.57%. Regarding short-term risk, MTD is less volatile compared to BIAF. This indicates lower risk in terms of short-term price fluctuations for MTD.Check BIAF's competition here
Chembio Diagnostics, Inc. (NASDAQ: CEMI)
MTD vs CEMI Comparison October 2026
Mettler-Toledo International Inc. (NYSE: MTD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MTD stands at 33.5B. In comparison, CEMI has a market cap of 16.7M. Regarding current trading prices, MTD is priced at $1,669.62 on the NYSE, while CEMI trades at $0.46.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MTD currently has a P/E ratio of 38.40, whereas CEMI's P/E ratio is -0.63. In terms of profitability, MTD's ROE is -12.00%, compared to CEMI's ROE of -0.89%. Regarding short-term risk, MTD is more volatile compared to CEMI. This indicates higher risk in terms of short-term price fluctuations for MTD.Check CEMI's competition here
Enzo Biochem, Inc. (NYSE: ENZ)
MTD vs ENZ Comparison October 2026
Mettler-Toledo International Inc. (NYSE: MTD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MTD stands at 33.5B. In comparison, ENZ has a market cap of 16.4M. Regarding current trading prices, MTD is priced at $1,669.62 on the NYSE, while ENZ trades at $0.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MTD currently has a P/E ratio of 38.40, whereas ENZ's P/E ratio is -2.24. In terms of profitability, MTD's ROE is -12.00%, compared to ENZ's ROE of -0.39%. Regarding short-term risk, MTD is less volatile compared to ENZ. This indicates lower risk in terms of short-term price fluctuations for MTD.Check ENZ's competition here
Psychemedics Corporation (NASDAQ: PMD)
MTD vs PMD Comparison October 2026
Mettler-Toledo International Inc. (NYSE: MTD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MTD stands at 33.5B. In comparison, PMD has a market cap of 15.6M. Regarding current trading prices, MTD is priced at $1,669.62 on the NYSE, while PMD trades at $2.67.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MTD currently has a P/E ratio of 38.40, whereas PMD's P/E ratio is -5.24. In terms of profitability, MTD's ROE is -12.00%, compared to PMD's ROE of -0.32%. Regarding short-term risk, MTD is more volatile compared to PMD. This indicates higher risk in terms of short-term price fluctuations for MTD.Check PMD's competition here
23andMe Holding Co. (NASDAQ: ME)
MTD vs ME Comparison October 2026
Mettler-Toledo International Inc. (NYSE: MTD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MTD stands at 33.5B. In comparison, ME has a market cap of 15.3M. Regarding current trading prices, MTD is priced at $1,669.62 on the NYSE, while ME trades at $0.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MTD currently has a P/E ratio of 38.40, whereas ME's P/E ratio is -0.03. In terms of profitability, MTD's ROE is -12.00%, compared to ME's ROE of -3.47%. Regarding short-term risk, MTD is more volatile compared to ME. This indicates higher risk in terms of short-term price fluctuations for MTD.Check ME's competition here
Mainz Biomed B.V. (NASDAQ: MYNZ)
MTD vs MYNZ Comparison October 2026
Mettler-Toledo International Inc. (NYSE: MTD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MTD stands at 33.5B. In comparison, MYNZ has a market cap of 14.7M. Regarding current trading prices, MTD is priced at $1,669.62 on the NYSE, while MYNZ trades at $3.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MTD currently has a P/E ratio of 38.40, whereas MYNZ's P/E ratio is -1.33. In terms of profitability, MTD's ROE is -12.00%, compared to MYNZ's ROE of -1.80%. Regarding short-term risk, MTD is less volatile compared to MYNZ. This indicates lower risk in terms of short-term price fluctuations for MTD.Check MYNZ's competition here
Burning Rock Biotech Limited (NASDAQ: BNR)
MTD vs BNR Comparison October 2026
Mettler-Toledo International Inc. (NYSE: MTD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MTD stands at 33.5B. In comparison, BNR has a market cap of 11.8M. Regarding current trading prices, MTD is priced at $1,669.62 on the NYSE, while BNR trades at $11.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MTD currently has a P/E ratio of 38.40, whereas BNR's P/E ratio is -12.82. In terms of profitability, MTD's ROE is -12.00%, compared to BNR's ROE of -0.13%. Regarding short-term risk, MTD is less volatile compared to BNR. This indicates lower risk in terms of short-term price fluctuations for MTD.Check BNR's competition here
Check-Cap Ltd. (NASDAQ: CHEK)
MTD vs CHEK Comparison October 2026
Mettler-Toledo International Inc. (NYSE: MTD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MTD stands at 33.5B. In comparison, CHEK has a market cap of 10.9M. Regarding current trading prices, MTD is priced at $1,669.62 on the NYSE, while CHEK trades at $1.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MTD currently has a P/E ratio of 38.40, whereas CHEK's P/E ratio is -0.43. In terms of profitability, MTD's ROE is -12.00%, compared to CHEK's ROE of -2.26%. Regarding short-term risk, MTD is less volatile compared to CHEK. This indicates lower risk in terms of short-term price fluctuations for MTD.Check CHEK's competition here
Centogene N.V. (NASDAQ: CNTG)
MTD vs CNTG Comparison October 2026
Mettler-Toledo International Inc. (NYSE: MTD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MTD stands at 33.5B. In comparison, CNTG has a market cap of 9.4M. Regarding current trading prices, MTD is priced at $1,669.62 on the NYSE, while CNTG trades at $0.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MTD currently has a P/E ratio of 38.40, whereas CNTG's P/E ratio is -0.23. In terms of profitability, MTD's ROE is -12.00%, compared to CNTG's ROE of +3.98%. Regarding short-term risk, MTD is more volatile compared to CNTG. This indicates higher risk in terms of short-term price fluctuations for MTD.Check CNTG's competition here
bioAffinity Technologies, Inc. (NASDAQ: BIAFW)
MTD vs BIAFW Comparison October 2026
Mettler-Toledo International Inc. (NYSE: MTD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MTD stands at 33.5B. In comparison, BIAFW has a market cap of 7.8M. Regarding current trading prices, MTD is priced at $1,669.62 on the NYSE, while BIAFW trades at $0.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MTD currently has a P/E ratio of 38.40, whereas BIAFW's P/E ratio is 0.83. In terms of profitability, MTD's ROE is -12.00%, compared to BIAFW's ROE of -2.57%. Regarding short-term risk, MTD is less volatile compared to BIAFW. This indicates lower risk in terms of short-term price fluctuations for MTD.Check BIAFW's competition here
ENDRA Life Sciences Inc. (NASDAQ: NDRA)
MTD vs NDRA Comparison October 2026
Mettler-Toledo International Inc. (NYSE: MTD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MTD stands at 33.5B. In comparison, NDRA has a market cap of 7.3M. Regarding current trading prices, MTD is priced at $1,669.62 on the NYSE, while NDRA trades at $4.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MTD currently has a P/E ratio of 38.40, whereas NDRA's P/E ratio is -0.73. In terms of profitability, MTD's ROE is -12.00%, compared to NDRA's ROE of -2.25%. Regarding short-term risk, MTD is less volatile compared to NDRA. This indicates lower risk in terms of short-term price fluctuations for MTD.Check NDRA's competition here
Applied DNA Sciences, Inc. (NASDAQ: APDN)
MTD vs APDN Comparison October 2026
Mettler-Toledo International Inc. (NYSE: MTD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MTD stands at 33.5B. In comparison, APDN has a market cap of 7.3M. Regarding current trading prices, MTD is priced at $1,669.62 on the NYSE, while APDN trades at $5.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MTD currently has a P/E ratio of 38.40, whereas APDN's P/E ratio is -0.10. In terms of profitability, MTD's ROE is -12.00%, compared to APDN's ROE of -7.23%. Regarding short-term risk, MTD is less volatile compared to APDN. This indicates lower risk in terms of short-term price fluctuations for MTD.Check APDN's competition here
Invitae Corporation (NYSE: NVTA)
MTD vs NVTA Comparison October 2026
Mettler-Toledo International Inc. (NYSE: MTD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MTD stands at 33.5B. In comparison, NVTA has a market cap of 5.4M. Regarding current trading prices, MTD is priced at $1,669.62 on the NYSE, while NVTA trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MTD currently has a P/E ratio of 38.40, whereas NVTA's P/E ratio is -0.00. In terms of profitability, MTD's ROE is -12.00%, compared to NVTA's ROE of -2.02%. Regarding short-term risk, MTD is less volatile compared to NVTA. This indicates lower risk in terms of short-term price fluctuations for MTD.Check NVTA's competition here
LumiraDx Limited (NASDAQ: LMDXW)
MTD vs LMDXW Comparison October 2026
Mettler-Toledo International Inc. (NYSE: MTD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MTD stands at 33.5B. In comparison, LMDXW has a market cap of 5.1M. Regarding current trading prices, MTD is priced at $1,669.62 on the NYSE, while LMDXW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MTD currently has a P/E ratio of 38.40, whereas LMDXW's P/E ratio is -0.00. In terms of profitability, MTD's ROE is -12.00%, compared to LMDXW's ROE of -15.58%. Regarding short-term risk, MTD is less volatile compared to LMDXW. This indicates lower risk in terms of short-term price fluctuations for MTD.Check LMDXW's competition here
LumiraDx Limited (NASDAQ: LMDX)
MTD vs LMDX Comparison October 2026
Mettler-Toledo International Inc. (NYSE: MTD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MTD stands at 33.5B. In comparison, LMDX has a market cap of 5.1M. Regarding current trading prices, MTD is priced at $1,669.62 on the NYSE, while LMDX trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MTD currently has a P/E ratio of 38.40, whereas LMDX's P/E ratio is -0.01. In terms of profitability, MTD's ROE is -12.00%, compared to LMDX's ROE of -15.58%. Regarding short-term risk, MTD is less volatile compared to LMDX. This indicates lower risk in terms of short-term price fluctuations for MTD.Check LMDX's competition here
Advanced Biomed Inc. Common Stock (NASDAQ: ADVB)
MTD vs ADVB Comparison October 2026
Mettler-Toledo International Inc. (NYSE: MTD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MTD stands at 33.5B. In comparison, ADVB has a market cap of 4.7M. Regarding current trading prices, MTD is priced at $1,669.62 on the NYSE, while ADVB trades at $2.73.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MTD currently has a P/E ratio of 38.40, whereas ADVB's P/E ratio is -25.73. In terms of profitability, MTD's ROE is -12.00%, compared to ADVB's ROE of +1.22%. Regarding short-term risk, MTD is less volatile compared to ADVB. This indicates lower risk in terms of short-term price fluctuations for MTD.Check ADVB's competition here
DermTech, Inc. (NASDAQ: DMTK)
MTD vs DMTK Comparison October 2026
Mettler-Toledo International Inc. (NYSE: MTD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MTD stands at 33.5B. In comparison, DMTK has a market cap of 3.3M. Regarding current trading prices, MTD is priced at $1,669.62 on the NYSE, while DMTK trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MTD currently has a P/E ratio of 38.40, whereas DMTK's P/E ratio is -0.04. In terms of profitability, MTD's ROE is -12.00%, compared to DMTK's ROE of -1.06%. Regarding short-term risk, MTD is less volatile compared to DMTK. This indicates lower risk in terms of short-term price fluctuations for MTD.Check DMTK's competition here
Inotiv, Inc. (NASDAQ: NOTV)
MTD vs NOTV Comparison October 2026
Mettler-Toledo International Inc. (NYSE: MTD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MTD stands at 33.5B. In comparison, NOTV has a market cap of 2.8M. Regarding current trading prices, MTD is priced at $1,669.62 on the NYSE, while NOTV trades at $0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MTD currently has a P/E ratio of 38.40, whereas NOTV's P/E ratio is -0.03. In terms of profitability, MTD's ROE is -12.00%, compared to NOTV's ROE of -0.75%. Regarding short-term risk, MTD is less volatile compared to NOTV. This indicates lower risk in terms of short-term price fluctuations for MTD.Check NOTV's competition here
SeqLL Inc. (NASDAQ: SQL)
MTD vs SQL Comparison October 2026
Mettler-Toledo International Inc. (NYSE: MTD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MTD stands at 33.5B. In comparison, SQL has a market cap of 2.5M. Regarding current trading prices, MTD is priced at $1,669.62 on the NYSE, while SQL trades at $6.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MTD currently has a P/E ratio of 38.40, whereas SQL's P/E ratio is -0.40. In terms of profitability, MTD's ROE is -12.00%, compared to SQL's ROE of -30.46%. Regarding short-term risk, MTD is less volatile compared to SQL. This indicates lower risk in terms of short-term price fluctuations for MTD.Check SQL's competition here
Aspira Women's Health Inc. (NASDAQ: AWH)
MTD vs AWH Comparison October 2026
Mettler-Toledo International Inc. (NYSE: MTD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MTD stands at 33.5B. In comparison, AWH has a market cap of 2.5M. Regarding current trading prices, MTD is priced at $1,669.62 on the NYSE, while AWH trades at $0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MTD currently has a P/E ratio of 38.40, whereas AWH's P/E ratio is -0.09. In terms of profitability, MTD's ROE is -12.00%, compared to AWH's ROE of +1.62%. Regarding short-term risk, MTD is more volatile compared to AWH. This indicates higher risk in terms of short-term price fluctuations for MTD.Check AWH's competition here
iSpecimen Inc. (NASDAQ: ISPC)
MTD vs ISPC Comparison October 2026
Mettler-Toledo International Inc. (NYSE: MTD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MTD stands at 33.5B. In comparison, ISPC has a market cap of 2.1M. Regarding current trading prices, MTD is priced at $1,669.62 on the NYSE, while ISPC trades at $0.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MTD currently has a P/E ratio of 38.40, whereas ISPC's P/E ratio is -0.03. In terms of profitability, MTD's ROE is -12.00%, compared to ISPC's ROE of -5.24%. Regarding short-term risk, MTD is less volatile compared to ISPC. This indicates lower risk in terms of short-term price fluctuations for MTD.Check ISPC's competition here
HTG Molecular Diagnostics, Inc. (NASDAQ: HTGM)
MTD vs HTGM Comparison October 2026
Mettler-Toledo International Inc. (NYSE: MTD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MTD stands at 33.5B. In comparison, HTGM has a market cap of 1.1M. Regarding current trading prices, MTD is priced at $1,669.62 on the NYSE, while HTGM trades at $0.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MTD currently has a P/E ratio of 38.40, whereas HTGM's P/E ratio is -0.03. In terms of profitability, MTD's ROE is -12.00%, compared to HTGM's ROE of -2.73%. Regarding short-term risk, MTD is more volatile compared to HTGM. This indicates higher risk in terms of short-term price fluctuations for MTD.Check HTGM's competition here
Biocept, Inc. (NASDAQ: BIOC)
MTD vs BIOC Comparison October 2026
Mettler-Toledo International Inc. (NYSE: MTD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MTD stands at 33.5B. In comparison, BIOC has a market cap of 450.8K. Regarding current trading prices, MTD is priced at $1,669.62 on the NYSE, while BIOC trades at $0.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MTD currently has a P/E ratio of 38.40, whereas BIOC's P/E ratio is -0.01. In terms of profitability, MTD's ROE is -12.00%, compared to BIOC's ROE of -1.38%. Regarding short-term risk, MTD is less volatile compared to BIOC. This indicates lower risk in terms of short-term price fluctuations for MTD.Check BIOC's competition here
SeqLL Inc. (NASDAQ: SQLLW)
MTD vs SQLLW Comparison October 2026
Mettler-Toledo International Inc. (NYSE: MTD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MTD stands at 33.5B. In comparison, SQLLW has a market cap of 179.6K. Regarding current trading prices, MTD is priced at $1,669.62 on the NYSE, while SQLLW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MTD currently has a P/E ratio of 38.40, whereas SQLLW's P/E ratio is -0.00. In terms of profitability, MTD's ROE is -12.00%, compared to SQLLW's ROE of -30.46%. Regarding short-term risk, MTD is less volatile compared to SQLLW. This indicates lower risk in terms of short-term price fluctuations for MTD.Check SQLLW's competition here
GeneDx Holdings Corp. (NASDAQ: WGSWW)
MTD vs WGSWW Comparison October 2026
Mettler-Toledo International Inc. (NYSE: MTD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MTD stands at 33.5B. In comparison, WGSWW has a market cap of 5.8K. Regarding current trading prices, MTD is priced at $1,669.62 on the NYSE, while WGSWW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MTD currently has a P/E ratio of 38.40, whereas WGSWW's P/E ratio is -0.00. In terms of profitability, MTD's ROE is -12.00%, compared to WGSWW's ROE of -0.39%. Regarding short-term risk, MTD is more volatile compared to WGSWW. This indicates higher risk in terms of short-term price fluctuations for MTD.Check WGSWW's competition here
Danaher Corporation (NYSE: DHR-PA)
MTD vs DHR-PA Comparison October 2026
Mettler-Toledo International Inc. (NYSE: MTD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MTD stands at 33.5B. In comparison, DHR-PA has a market cap of 0. Regarding current trading prices, MTD is priced at $1,669.62 on the NYSE, while DHR-PA trades at $1,841.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MTD currently has a P/E ratio of 38.40, whereas DHR-PA's P/E ratio is 233.57. In terms of profitability, MTD's ROE is -12.00%, compared to DHR-PA's ROE of +0.08%. Regarding short-term risk, MTD is less volatile compared to DHR-PA. This indicates lower risk in terms of short-term price fluctuations for MTD.Check DHR-PA's competition here
ENDRA Life Sciences Inc. Warrants (NASDAQ: NDRAW)
MTD vs NDRAW Comparison October 2026
Mettler-Toledo International Inc. (NYSE: MTD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MTD stands at 33.5B. In comparison, NDRAW has a market cap of 0. Regarding current trading prices, MTD is priced at $1,669.62 on the NYSE, while NDRAW trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MTD currently has a P/E ratio of 38.40, whereas NDRAW's P/E ratio is N/A. In terms of profitability, MTD's ROE is -12.00%, compared to NDRAW's ROE of -2.25%. Regarding short-term risk, MTD is less volatile compared to NDRAW. This indicates lower risk in terms of short-term price fluctuations for MTD.Check NDRAW's competition here
23andMe Holding Co. (NASDAQ: MEUSW)
MTD vs MEUSW Comparison October 2026
Mettler-Toledo International Inc. (NYSE: MTD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MTD stands at 33.5B. In comparison, MEUSW has a market cap of 0. Regarding current trading prices, MTD is priced at $1,669.62 on the NYSE, while MEUSW trades at $1.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MTD currently has a P/E ratio of 38.40, whereas MEUSW's P/E ratio is N/A. In terms of profitability, MTD's ROE is -12.00%, compared to MEUSW's ROE of -3.47%. Regarding short-term risk, MTD is less volatile compared to MEUSW. This indicates lower risk in terms of short-term price fluctuations for MTD.Check MEUSW's competition here
PAREXEL Intl Corp. (NASDAQ: PRXL)
MTD vs PRXL Comparison October 2026
Mettler-Toledo International Inc. (NYSE: MTD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MTD stands at 33.5B. In comparison, PRXL has a market cap of 0. Regarding current trading prices, MTD is priced at $1,669.62 on the NYSE, while PRXL trades at $88.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MTD currently has a P/E ratio of 38.40, whereas PRXL's P/E ratio is 42.97. In terms of profitability, MTD's ROE is -12.00%, compared to PRXL's ROE of +0.17%. Regarding short-term risk, MTD is more volatile compared to PRXL. This indicates higher risk in terms of short-term price fluctuations for MTD.Check PRXL's competition here
Ortho Clinical Diagnostics Holdings plc (NASDAQ: OCDX)
MTD vs OCDX Comparison October 2026
Mettler-Toledo International Inc. (NYSE: MTD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MTD stands at 33.5B. In comparison, OCDX has a market cap of 0. Regarding current trading prices, MTD is priced at $1,669.62 on the NYSE, while OCDX trades at $17.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MTD currently has a P/E ratio of 38.40, whereas OCDX's P/E ratio is -42.28. In terms of profitability, MTD's ROE is -12.00%, compared to OCDX's ROE of +0.18%. Regarding short-term risk, MTD is less volatile compared to OCDX. This indicates lower risk in terms of short-term price fluctuations for MTD.Check OCDX's competition here
Check-Cap Ltd (NASDAQ: CHEKZ)
MTD vs CHEKZ Comparison October 2026
Mettler-Toledo International Inc. (NYSE: MTD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MTD stands at 33.5B. In comparison, CHEKZ has a market cap of 0. Regarding current trading prices, MTD is priced at $1,669.62 on the NYSE, while CHEKZ trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MTD currently has a P/E ratio of 38.40, whereas CHEKZ's P/E ratio is N/A. In terms of profitability, MTD's ROE is -12.00%, compared to CHEKZ's ROE of +4.17%. Regarding short-term risk, MTD is less volatile compared to CHEKZ. This indicates lower risk in terms of short-term price fluctuations for MTD.Check CHEKZ's competition here
BioNano Genomics, Inc. WT EXP 082123 (NASDAQ: BNGOW)
MTD vs BNGOW Comparison October 2026
Mettler-Toledo International Inc. (NYSE: MTD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MTD stands at 33.5B. In comparison, BNGOW has a market cap of 0. Regarding current trading prices, MTD is priced at $1,669.62 on the NYSE, while BNGOW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MTD currently has a P/E ratio of 38.40, whereas BNGOW's P/E ratio is N/A. In terms of profitability, MTD's ROE is -12.00%, compared to BNGOW's ROE of -0.79%. Regarding short-term risk, MTD is less volatile compared to BNGOW. This indicates lower risk in terms of short-term price fluctuations for MTD.Check BNGOW's competition here